Inovio Pharmaceuticals, Inc. (INO)
1.16
-0.05
(-4.13%)
USD |
NASDAQ |
Oct 02, 16:00
1.18
+0.02
(+1.72%)
After-Hours: 20:00
Inovio Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -1.04K% |
| December 31, 2024 | -563.1% |
| September 30, 2024 | |
| June 30, 2024 | -722.1% |
| March 31, 2024 | |
| December 31, 2023 | -70.69% |
| September 30, 2023 | -165.9% |
| June 30, 2023 | -405.9% |
| March 31, 2023 | -902.7% |
| December 31, 2022 | -981.4% |
| September 30, 2022 | 85.12% |
| June 30, 2022 | -79.77% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | -64.37% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
| December 31, 2013 | 0.00% |
| September 30, 2013 | 0.00% |
| June 30, 2013 | 0.00% |
| March 31, 2013 | 0.00% |
| December 31, 2012 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | 98.46% |
| Ironwood Pharmaceuticals, Inc. | 99.60% |
| Fortress Biotech, Inc. | 61.50% |
| Tonix Pharmaceuticals Holding Corp. | 90.24% |
| Kura Oncology, Inc. | 97.07% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -609.1% |
| Return on Assets | -107.9% |
| Return on Invested Capital | -330.2% |
| Return on Net Operating Assets | -541.8% |